Mannkind reported $48.35M in Current Liabilities for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adma Biologics ADMA:US $ 31.57M 1.19M
Biocryst Pharmaceuticals BCRX:US $ 81.02M 22.7M
Halozyme Therapeutics HALO:US $ 111.69M 5.46M
Immunogen IMGN:US $ 84.12M 16.83M
Insmed INSM:US $ 125.25M 9.92M
JAZZ PHA JAZZ:US $ 737.41M 71.89M
Minerva Neurosciences NERV:US $ 3.25M 0.43M
Peregrine Pharmaceuticals PPHM:US $ 69.53M 6.28M
Xencor XNCR:US $ 60.94M 9.8M